These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36267705)

  • 1. Identification of key genes and pathway related to chemoresistance of small cell lung cancer through an integrative bioinformatics analysis.
    Zeng FR; Zhou XY; Zeng LG; Sun JC; He F; Mo W; Wen Y; Wang SY; Liu Q; Guo LL
    Ann Transl Med; 2022 Sep; 10(18):968. PubMed ID: 36267705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression.
    Cao J; Yuan L
    Front Cardiovasc Med; 2022; 9():946229. PubMed ID: 35990977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis.
    Liao Y; Yin G; Wang X; Zhong P; Fan X; Huang C
    Oncol Lett; 2019 Oct; 18(4):3723-3733. PubMed ID: 31516585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel hub genes and lncRNAs related to the prognosis and progression of pancreatic cancer by microarray and integrated bioinformatics analysis.
    Liang X; Peng J; Chen D; Tang L; Liu A; Fu Z; Shi L; Wang K; Shao C
    Gland Surg; 2021 Mar; 10(3):1104-1117. PubMed ID: 33842254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation.
    Yin Y; Li D; He M; Wang J
    Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of key long non-coding RNAs using co-expression network analysis in Crohn's disease.
    Rui Q; Lu C; Song S; Zhang L
    Ann Palliat Med; 2021 Sep; 10(9):9627-9639. PubMed ID: 34628888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
    Guo M; Dai Y; Jiang L; Gao J
    Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Molecular Mechanisms of Pterygium by Constructing lncRNA-miRNA-mRNA Regulatory Network.
    Xu N; Cui Y; Dong J; Huang L
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):12. PubMed ID: 32645133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole Transcriptomic Analysis of Key Genes and Signaling Pathways in Endogenous ARDS.
    Xie Y; Luo J; Hu W; Ye C; Ren P; Wang Y; Li X
    Dis Markers; 2022; 2022():1614208. PubMed ID: 36246560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1.
    Chen R; Li D; Zheng M; Chen B; Wei T; Wang Y; Li M; Huang W; Tong Q; Wang Q; Zhu Y; Fang W; Guo L; Fang S
    J Cell Mol Med; 2020 Feb; 24(3):2123-2134. PubMed ID: 31957179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of an lncRNA-miRNA-mRNA competing endogenous RNA network in pulpitis.
    Lei F; Zhang H; Xie X
    PeerJ; 2019; 7():e7135. PubMed ID: 31304055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
    Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
    Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel lncRNAs involved in the pathogenesis of childhood acute lymphoblastic leukemia.
    Li S; Bian H; Cao Y; Juan C; Cao Q; Zhou G; Fang Y
    Oncol Lett; 2019 Feb; 17(2):2081-2090. PubMed ID: 30675275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HuR affects chemoresistance of small cell lung cancer by regulating FGFRL1 expression.
    Duan XH; Chen R; Li DS; Luo AH; Guo LL
    Exp Ther Med; 2022 Oct; 24(4):638. PubMed ID: 36160905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of chemoresistance-associated miRNAs in breast cancer.
    Lou W; Liu J; Ding B; Xu L; Fan W
    Cancer Manag Res; 2018; 10():4747-4757. PubMed ID: 30425571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses.
    Wu Y; Xia L; Guo Q; Zhu J; Deng Y; Wu X
    Cancer Manag Res; 2020; 12():5213-5223. PubMed ID: 32636682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.